newatlas.com / .newatlas-com-medical / Page 5

Scientists have developed smart insoles that accurately measure the forces created when a foot hits the ground in the real world. The innovative tech has a range of applications, from assisting in rehabilitating injured patients to helping athletes . ...

Researchers at the National University of Singapore (NUS) have hit upon new technologies to deliver a double whammy to chronic wounds in diabetics, using tiny needles barely visible to the human eye.

Extracts made from parts of the cashew plant that are usually thrown away when the nuts are processed commercially were found to significantly limit the development of fat cells and the accumulation of fat, according to new research. It suggests the ...

In seeking new antibiotic sources, researchers have turned to an unlikely source: a whiffy frog known as Odorrana andersonii. By unclumping a compound it produces naturally, they've found a potential gut-friendly ally in the fight against superbugs.

Scientists have made a major breakthrough in the accuracy and speed at which often deadly pathogen infections can be identified and treated. This is time that, in many cases, is critical to saving a patient's life.

A study comparing people in monogamous relationships with those in non-monogamous ones has found that both types are on par insofar as relationship and sexual satisfaction are concerned. It suggests the need for greater recognition of and respect for ...

More than a million people of nearly all ages lace up their trainers and hit the pavement in a marathon every year. And while running any distance has numerous health benefits, researchers warn that going the distance may not be so good for the brain ...

New research found that taking a placebo pill, knowing that it contains no active ingredients, reduced the intensity of premenstrual syndrome (PMS) symptoms by a whopping 79%, substantially more than taking the usual side-effect-causing medications.

For many people, injection needles can be scary - and the larger ones for specialized longer-term medications are far more intimidating.

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year.